Tps. Oei et Wal. Loveday, MANAGEMENT OF CO-MORBID ANXIETY AND ALCOHOL DISORDERS - PARALLEL TREATMENT OF DISORDERS, Drug and alcohol review, 16(3), 1997, pp. 261-274
Co-morbid alcohol-related disorders and anxiety disorders have been fo
und to occur in alcohol treatment populations, anxiety treatment popul
ations and the general community. People suffering from co-occurring a
lcohol-related and anxiety disorders are more prone to relapse to alco
hol abuse, and more likely to re-enter the treatment system for either
disorder than sufferers of either disorder without a co-morbid disord
er. To review the current state of the management of this disorder, ev
idence of the prevalence of this co-morbid condition in clinical and c
ommunity populations is examined, then the theoretical mechanisms that
might explain this connection are reviewed. A comparison of the few t
reatment studies of co-morbid alcohol and anxiety disorders shows a li
mited number of pharmacological treatment trials and no psychotherapy
outcome trials. This review shows that it is no longer sustainable to
conceptualize co-morbidity of alcohol and anxiety disorders as a unita
ry concept, i.e. lumping alcohol-related and anxiety disorders as one
global condition, but as separate distinct combinations of particular
anxiety disorders, e.g. alcohol dependence and panic disorder, alcohol
dependence and generalized anxiety disorder. The recommended treatmen
t approach, supported by the evidence, is to offer separate and parall
el therapy fbr the alcohol-related and anxiety disorder, until empiric
al evidence from treatment outcome studies suggest otherwise. There is
an urgent need to conduct treatment outcome research for the subtypes
of co-morbid alcohol and anxiety disorders.